StockData
Wave Life Sciences, Inc. logo

Wave Life Sciences, Inc. (WVE) stock

WVENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 10/3046% below fair value
$2.77−0.07 (-2.46%)

Close on Nov 18, 2026Market cap $546.32MP/E –Yield –

Wave Life Sciences operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Wave Life Sciences's operating income for the twelve months ending Sep 30, 2026 was -$227.61M. For fiscal 2025 it was -$215.38M. The highest annual figure on record is -$3.57M in fiscal 2013.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$215.38M–
FY2024Dec 31, 2024-$110.40M–
FY2023Dec 31, 2023-$68.00M–
FY2022Dec 31, 2022-$162.72M–
FY2021Dec 31, 2021-$127.02M–
FY2020Dec 31, 2020-$153.38M–
FY2019Dec 31, 2019-$208.32M–
FY2018Dec 31, 2018-$159.52M–
FY2017Dec 31, 2017-$102.39M–
FY2016Dec 31, 2016-$55.72M–
FY2015Dec 31, 2015-$19.30M–
FY2014Dec 31, 2014-$5.39M–
FY2013Dec 31, 2013-$3.57M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$66.05M–
Q2 FY2026Jun 30, 2026-$73.80M–
Q1 FY2026Mar 31, 2026-$31.30M–
Q4 FY2025Dec 31, 2025-$56.47M-345.9%
Q3 FY2025Sep 30, 2025-$56.35M–
Q2 FY2025Jun 30, 2025-$52.76M–
Q1 FY2025Mar 31, 2025-$49.80M–
Q4 FY2024Dec 31, 2024$22.97M–
Q3 FY2024Sep 30, 2024-$63.92M-1538.2%
Q2 FY2024Jun 30, 2024-$35.00M–
Q1 FY2024Mar 31, 2024-$34.46M–
Q4 FY2023Dec 31, 2023-$18.68M–
Q3 FY2023Sep 30, 2023$4.44M–
Q2 FY2023Jun 30, 2023-$23.47M–
Q1 FY2023Mar 31, 2023-$30.29M–
Q4 FY2022Dec 31, 2022-$43.56M–
Q3 FY2022Sep 30, 2022-$38.90M–
Q2 FY2022Jun 30, 2022-$42.16M–
Q1 FY2022Mar 31, 2022-$38.09M–
Q4 FY2021Dec 31, 2021-$36.11M–
Q3 FY2021Sep 30, 2021-$7.61M–
Q2 FY2021Jun 30, 2021-$39.83M–
Q1 FY2021Mar 31, 2021-$43.47M–
Q4 FY2020Dec 31, 2020-$30.31M–
Q3 FY2020Sep 30, 2020-$34.42M–
Q2 FY2020Jun 30, 2020-$38.66M–
Q1 FY2020Mar 31, 2020-$49.99M–
Q4 FY2019Dec 31, 2019-$60.53M–
Q3 FY2019Sep 30, 2019-$54.18M–
Q2 FY2019Jun 30, 2019-$45.62M–
Q1 FY2019Mar 31, 2019-$47.99M–
Q4 FY2018Dec 31, 2018-$48.94M–
Q3 FY2018Sep 30, 2018-$38.23M–
Q2 FY2018Jun 30, 2018-$36.57M–
Q1 FY2018Mar 31, 2018-$35.78M–
Q4 FY2017Dec 31, 2017-$31.16M–
Q3 FY2017Sep 30, 2017-$26.35M–
Q2 FY2017Jun 30, 2017-$24.67M–
Q1 FY2017Mar 31, 2017-$20.21M–
Q4 FY2016Dec 31, 2016-$18.50M–

More Wave Life Sciences figures

See a number that looks wrong?